Seek Returns

MTD vs. TEM: Mettler-Toledo vs. Tempus AI Stock Comparison

How do Mettler-Toledo (MTD) and Tempus AI (TEM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Mettler-Toledo (MTD) and Tempus AI (TEM) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Mettler-Toledo (MTD) carries decades of public-market history since November 14, 1997, while Tempus AI (TEM) listed on June 14, 2024 — long-window comparisons have far more historical data on the MTD side.

Company profile comparison for Mettler-Toledo (MTD) and Tempus AI (TEM)
Profile ItemMTDTEM
NameMettler-Toledo International Inc.Tempus AI Inc Class A Common Stock
Country/RegionSwitzerlandUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization34.25 billion USD13.87 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateNovember 14, 1997June 14, 2024
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

MTD
TEM
GSPC
Loading price history…
Mettler-Toledo (MTD) vs. Tempus AI (TEM), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Mettler-Toledo (MTD) and Tempus AI (TEM). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Mettler-Toledo (MTD) and Tempus AI (TEM). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Total Return (1Y)21.58%16.25%
Total Return (3Y, Annualized)19.54%--
Total Return (5Y, Annualized)2.36%--

Risk Profile

Drawdown History

MTD
TEM
GSPC
Loading price history…
Mettler-Toledo (MTD) vs. Tempus AI (TEM), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Mettler-Toledo (MTD) and Tempus AI (TEM). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Tempus AI (TEM) carries a highly aggressive beta of 3.34, indicating much higher sensitivity to broad-market moves, whereas Mettler-Toledo (MTD) is closer to market-like at 1.15 — a noticeable difference in market-sensitivity profile.

Risk profile metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Volatility (1Y, Annualized)31.70%76.08%
Beta (5Y)1.153.34
Max Drawdown (5Y)-43.47%-59.76%
Avg. Volume (3M)197.80K7.20M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
MTD and TEM are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Sharpe Ratio (1Y)0.550.16
Sortino Ratio (1Y)0.750.26

Profitability

ROE (TTM)

Mettler-Toledo (MTD) has no ROE value reported for this period; Tempus AI (TEM) reports a negative figure of -37.55%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
MTD
--

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-37.55%

Max
109.18%
Q3
6.23%
Median
-26.66%
TEM
-37.55%
Q1
-64.05%
Min
-167.77%
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): MTD does not report ROE, so it has no value marker; TEM is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Tempus AI (TEM) reports a negative net margin of -12.54%, usually indicating a net loss over the period. Meanwhile Mettler-Toledo (MTD) reports 22.25%, ranking against industry peers normally.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

22.25%

MTD
22.25%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-12.54%

Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
TEM
-12.54%
Min
-17.05%
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Tempus AI (TEM) reports a negative operating margin of -13.82%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Mettler-Toledo (MTD) reports 28.70%, ranking against industry peers normally.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

28.70%

Max
83.12%
MTD
28.70%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-13.82%

Max
83.12%
Q3
14.77%
Median
0.00%
TEM
-13.82%
Q1
-78.82%
Min
-207.40%
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
ROE (TTM)---37.55%
ROA (TTM)20.09%-7.36%
Net Margin (TTM)22.25%-12.54%
Operating Margin (TTM)28.70%-13.82%
Gross Margin (TTM)59.16%64.46%

Growth

Revenue Growth

Tempus AI (TEM) at 83.41% sits in the top revenue growth quartile, while Mettler-Toledo (MTD) at 3.98% is closer to the peer norm — faster top-line expansion for TEM.

Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Mettler-Toledo (MTD) reports EPS growth of 3.88%, ranked against its industry; Tempus AI (TEM) has no EPS growth figure this period.

Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Revenue Growth (YoY)3.98%83.41%
Revenue Growth (3Y CAGR)0.90%58.29%
EPS Growth (YoY)3.88%--
EPS Growth (3Y CAGR)3.06%--

Financial Strength

Current Ratio (MRQ)

Tempus AI (TEM) at 2.61 keeps current ratio within its industry’s typical mid-range, while Mettler-Toledo (MTD) at 1.10 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for MTD.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.10

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
MTD
1.10
Min
0.10

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.61

Max
25.13
Q3
12.13
Median
5.52
TEM
2.61
Q1
2.47
Min
0.10
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Debt sits unusually high against shareholders’ equity for both Mettler-Toledo (MTD) at 26.06 and Tempus AI (TEM) at 2.86 — each debt-to-equity ratio is above its industry benchmark range.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

26.06

MTD
26.06
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.86

TEM
2.86
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Current Ratio (MRQ)1.102.61
Debt / Equity (MRQ)26.062.86
Net Debt / EBITDA1.58--

Dividends

Dividend Yield (TTM)

Neither Mettler-Toledo (MTD) nor Tempus AI (TEM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

TEM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Mettler-Toledo (MTD) nor Tempus AI (TEM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

TEM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Mettler-Toledo (MTD) trades at 37.38 times trailing earnings, ranked against its peers, while Tempus AI (TEM) has no P/E ratio this period.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

37.38

Max
85.34
Q3
43.46
MTD
37.38
Median
26.69
Q1
13.30
Min
0.07

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
TEM
--
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): TEM does not report P/E ratio, so it has no value marker; MTD is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

On P/S ratio, both Mettler-Toledo (MTD) at 8.16 and Tempus AI (TEM) at 9.19 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max
58.18
Q3
25.77
MTD
8.16
Median
7.30
Q1
3.01
Min
0.01

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.19

Max
58.18
Q3
25.77
TEM
9.19
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Measured against book value, both Mettler-Toledo (MTD) at 442.71 and Tempus AI (TEM) at 27.66 look expensive — each P/B ratio sits above its industry’s benchmark range.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

442.71

MTD
442.71
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.66

TEM
27.66
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Mettler-Toledo (MTD) vs. Tempus AI (TEM): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Mettler-Toledo (MTD) and Tempus AI (TEM)
MetricMTDTEM
P/E Ratio (TTM)37.38--
P/S Ratio (TTM)8.169.19
P/B Ratio (MRQ)442.7127.66
Free Cash Flow Yield (TTM)1.97%0.30%